Yuji Hiromatsu

3.3k total citations
101 papers, 2.5k citations indexed

About

Yuji Hiromatsu is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Yuji Hiromatsu has authored 101 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Pathology and Forensic Medicine and 25 papers in Genetics. Recurrent topics in Yuji Hiromatsu's work include Ophthalmology and Eye Disorders (42 papers), Thyroid Disorders and Treatments (29 papers) and Diabetes and associated disorders (16 papers). Yuji Hiromatsu is often cited by papers focused on Ophthalmology and Eye Disorders (42 papers), Thyroid Disorders and Treatments (29 papers) and Diabetes and associated disorders (16 papers). Yuji Hiromatsu collaborates with scholars based in Japan, Canada and Poland. Yuji Hiromatsu's co-authors include Kyohei Nonaka, Ikuyo Miyake, Tomasz Bednarczuk, Shuji Toda, Jack R. Wall, Masatoshi Ishibashi, Masayuki Sato, Hiroshi Fukazawa, Jacques How and Junichi Tani and has published in prestigious journals such as Endocrine Reviews, The Journal of Clinical Endocrinology & Metabolism and Life Sciences.

In The Last Decade

Yuji Hiromatsu

97 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuji Hiromatsu Japan 30 1.1k 976 488 462 436 101 2.5k
A. P. Weetman United Kingdom 31 1.3k 1.3× 489 0.5× 626 1.3× 442 1.0× 711 1.6× 77 2.5k
K Kasagi Japan 30 2.1k 2.0× 271 0.3× 345 0.7× 390 0.8× 174 0.4× 113 2.7k
Matthew J. Simmonds United Kingdom 25 755 0.7× 233 0.2× 1.0k 2.1× 393 0.9× 892 2.0× 50 2.5k
Francis S. Greenspan United States 24 2.0k 1.9× 300 0.3× 475 1.0× 363 0.8× 161 0.4× 55 2.7k
J. M. Heward United Kingdom 27 994 0.9× 216 0.2× 1.5k 3.2× 412 0.9× 1.0k 2.4× 39 2.6k
Emese Kiss Hungary 34 275 0.3× 888 0.9× 265 0.5× 352 0.8× 1.2k 2.8× 130 3.2k
G. F. Bottazzo United Kingdom 30 1.2k 1.2× 146 0.1× 1.1k 2.3× 379 0.8× 986 2.3× 65 3.2k
Swapan K. Nath United States 32 204 0.2× 209 0.2× 960 2.0× 838 1.8× 1.9k 4.3× 103 3.9k
Bobby P. C. Koeleman Netherlands 30 322 0.3× 95 0.1× 1.2k 2.5× 757 1.6× 666 1.5× 72 5.3k
Kathleen A. Donovan United States 20 146 0.1× 220 0.2× 259 0.5× 580 1.3× 481 1.1× 41 1.8k

Countries citing papers authored by Yuji Hiromatsu

Since Specialization
Citations

This map shows the geographic impact of Yuji Hiromatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Hiromatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Hiromatsu more than expected).

Fields of papers citing papers by Yuji Hiromatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Hiromatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Hiromatsu. The network helps show where Yuji Hiromatsu may publish in the future.

Co-authorship network of co-authors of Yuji Hiromatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Hiromatsu. A scholar is included among the top collaborators of Yuji Hiromatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Hiromatsu. Yuji Hiromatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kawasaki, Eiji, Yoko Sagara, Yuko Nakano, et al.. (2021). Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis. Journal of Diabetes Investigation. 13(4). 738–740. 6 indexed citations
4.
Hiromatsu, Yuji, et al.. (2020). Graves' Disease after Adrenalectomy for Cushing's Syndrome. Internal Medicine. 60(1). 99–103. 2 indexed citations
5.
Watanabe, Yoriko, Chikahiko Numakura, Takuji Torimura, et al.. (2020). Diabetes mellitus exacerbates citrin deficiency via glucose toxicity. Diabetes Research and Clinical Practice. 164. 108159–108159. 6 indexed citations
6.
Yatsuga, Shuichi, Yuji Hiromatsu, Shigekazu Sasaki, et al.. (2012). A two-day-old hyperthyroid neonate with thyroid hormone resistance born to a mother with well-controlled Graves’ disease: a case report. Journal of Medical Case Reports. 6(1). 246–246. 4 indexed citations
7.
Kaida, Hayato, Yuji Hiromatsu, Seiji Kurata, et al.. (2011). Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer. Nuclear Medicine Communications. 32(8). 690–698. 21 indexed citations
8.
Hiromatsu, Yuji. (2010). 1. Advances in the Pathogenesis and Management of Graves' Ophthalmopathy.. Nihon Naika Gakkai Zasshi. 99(4). 755–762. 1 indexed citations
9.
10.
Hiromatsu, Yuji, et al.. (2000). Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy*. The Journal of Clinical Endocrinology & Metabolism. 85(3). 1194–1199. 161 indexed citations
11.
Yang, Damu, Yuji Hiromatsu, Tomoaki Hoshino, et al.. (1999). Dominant Infiltration of TH 1-type CD4 + T Cells at the Retrobulbar Space of Patients with Thyroid-Associated Ophthalmopathy. Thyroid. 9(3). 305–310. 56 indexed citations
12.
Hiromatsu, Yuji, et al.. (1999). Immunohistochemical Analysis of Bcl-2, Bax, and Bak Expression in Thyroid Glands from Patients with Subacute Thyroiditis. The Journal of Clinical Endocrinology & Metabolism. 84(6). 2221–2225. 17 indexed citations
13.
Hiromatsu, Yuji, Tomasz Bednarczuk, Ikuyo Miyake, et al.. (1999). Increased Serum Soluble Fas in Patients with Graves' Disease. Thyroid. 9(4). 341–345. 25 indexed citations
14.
Hiromatsu, Yuji, et al.. (1998). Nicotinamide Decreases Cytokine-Induced Activation of Orbital Fibroblasts from Patients with Thyroid-Associated Ophthalmopathy. The Journal of Clinical Endocrinology & Metabolism. 83(1). 121–124. 30 indexed citations
15.
Hiromatsu, Yuji, et al.. (1994). Inhibitory Effect of FK506 on Intercellular Adhesion Molecule-1(ICAM-1) Expression on Cultured Thyroid Cells.. The Kurume Medical Journal. 41(2). 73–79. 2 indexed citations
16.
Hiromatsu, Yuji, Masayuki Sato, Kiyoko Tanaka, et al.. (1993). Significance of Anti-Eye Muscle Antibody in Patients with Thyroid-Associated Ophthalmopathy by Quantitative Western Blot. Autoimmunity. 14(1). 9–16. 23 indexed citations
17.
Hiromatsu, Yuji, et al.. (1993). Inhibitory effects of nicotinamide on intercellular adhesion molecule-1 expression on cultured human thyroid cells.. PubMed. 80(2). 330–2. 33 indexed citations
18.
Hiromatsu, Yuji, Masayuki Sato, Kentaro Yamada, & Kyohei Nonaka. (1992). Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells. Immunology Letters. 31(1). 35–39. 39 indexed citations
19.
Salvi, Mario, Hiroshi Fukazawa, Nicole F. Bernard, et al.. (1988). Role of Autoantibodies in the Pathogenesis and Association of Endocrine Autoimmune Disorders*. Endocrine Reviews. 9(4). 450–466. 52 indexed citations
20.
Hiromatsu, Yuji, et al.. (1986). Immunologically Mediated Cytotoxicity against Human Eye Muscle Cells in Graves’ Ophthalmopathy*. The Journal of Clinical Endocrinology & Metabolism. 63(2). 316–322. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. P. Weetman Breakdown of academic impact, for papers by K Kasagi Breakdown of academic impact, for papers by Matthew J. Simmonds Breakdown of academic impact, for papers by Francis S. Greenspan Breakdown of academic impact, for papers by J. M. Heward Breakdown of academic impact, for papers by Emese Kiss Breakdown of academic impact, for papers by G. F. Bottazzo Breakdown of academic impact, for papers by Swapan K. Nath Breakdown of academic impact, for papers by Bobby P. C. Koeleman Breakdown of academic impact, for papers by Kathleen A. Donovan
Rankless by CCL
2026